Eradivir

Developer of a novel bispecific immunotherapy platform designed for patients' immune systems to kill both viruses and virus-infected cells. The company offers ligands with high specificity and avidity...

Healthcare

West Lafayette, IN, United States

Founded 2020

21 employees

Website

Valuation

$113M

Market implied

Share Price

N/A

Total Raised

$30.1M

Last Round

N/A

Investors

+9 other investors

View all 9 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock Eradivir's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required